Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

TET-Catalyzed 5-Carboxylcytosine Promotes CTCF Binding to Suboptimal Sequences Genome-wide.

Nanan KK, Sturgill DM, Prigge MF, Thenoz M, Dillman AA, Mandler MD, Oberdoerffer S.

iScience. 2019 Sep 27;19:326-339. doi: 10.1016/j.isci.2019.07.041. Epub 2019 Jul 30.

2.

SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival.

Su H, Hu J, Huang L, Yang Y, Thenoz M, Kuchmiy A, Hu Y, Li P, Feng H, Zhou Y, Taghon T, Van Vlierberghe P, Qing G, Chen Z, Liu H.

Nat Commun. 2018 Oct 15;9(1):4281. doi: 10.1038/s41467-018-06523-4.

3.

Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia.

Milani G, Matthijssens F, Van Loocke W, Durinck K, Roels J, Peirs S, Thénoz M, Pieters T, Reunes L, Lintermans B, Vandamme N, Lammens T, Van Roy N, Van Nieuwerburgh F, Deforce D, Schwab C, Raimondi S, Dalla Pozza L, Carroll AJ 3rd, De Moerloose B, Benoit Y, Goossens S, Berx G, Harrison CJ, Basso G, Cavé H, Sutton R, Asnafi V, Meijerink J, Mullighan C, Loh M, Van Vlierberghe P.

Br J Haematol. 2019 Apr;185(1):169-174. doi: 10.1111/bjh.15425. Epub 2018 Jun 25. No abstract available.

PMID:
29938777
4.

TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing.

Marina RJ, Sturgill D, Bailly MA, Thenoz M, Varma G, Prigge MF, Nanan KK, Shukla S, Haque N, Oberdoerffer S.

EMBO J. 2016 Feb 1;35(3):335-55. doi: 10.15252/embj.201593235. Epub 2015 Dec 28.

5.

HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.

Idrissi ME, Hachem H, Koering C, Merle P, Thénoz M, Mortreux F, Wattel E.

J Viral Hepat. 2016 Feb;23(2):130-8. doi: 10.1111/jvh.12450. Epub 2015 Aug 28.

PMID:
26316075
6.

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).

Mohamed AM, Balsat M, Thenoz M, Koering C, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Michallet M, Thomas X, Nicolini F, Solly F, Guyotat D, Campos L, Wattel E, Mortreux F.

Oncotarget. 2016 Jan 19;7(3):2889-909. doi: 10.18632/oncotarget.3898.

7.

HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia.

Thénoz M, Vernin C, Mortada H, Karam M, Pinatel C, Gessain A, Webb TR, Auboeuf D, Wattel E, Mortreux F.

Retrovirology. 2014 Dec 18;11:119. doi: 10.1186/s12977-014-0119-3.

8.

How mRNA is misspliced in acute myelogenous leukemia (AML)?

Mohamed AM, Thénoz M, Solly F, Balsat M, Mortreux F, Wattel E.

Oncotarget. 2014 Oct 30;5(20):9534-45. Review.

9.

HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs.

Vernin C, Thenoz M, Pinatel C, Gessain A, Gout O, Delfau-Larue MH, Nazaret N, Legras-Lachuer C, Wattel E, Mortreux F.

Cancer Res. 2014 Nov 1;74(21):6082-93. doi: 10.1158/0008-5472.CAN-13-3564. Epub 2014 Sep 9.

10.

Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.

Karam M, Thenoz M, Capraro V, Robin JP, Pinatel C, Lancon A, Galia P, Sibon D, Thomas X, Ducastelle-Lepretre S, Nicolini F, El-Hamri M, Chelghoun Y, Wattel E, Mortreux F.

Neoplasia. 2014 Jan;16(1):21-30.

Supplemental Content

Loading ...
Support Center